$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Obesity and Cardiovascular Disease

Journal of the American College of Cardiology, v.53 no.21, 2009년, pp.1925 - 1932  

Lavie, C.J. ,  Milani, R.V. ,  Ventura, H.O.

Abstract AI-Helper 아이콘AI-Helper

Obesity has reached global epidemic proportions in both adults and children and is associated with numerous comorbidities, including hypertension (HTN), type II diabetes mellitus, dyslipidemia, obstructive sleep apnea and sleep-disordered breathing, certain cancers, and major cardiovascular (CV) dis...

주제어

참고문헌 (86)

  1. Circulation Poirier 113 898 2006 10.1161/CIRCULATIONAHA.106.171016 

  2. Circulation Klein 110 2952 2004 10.1161/01.CIR.0000145546.97738.1E 

  3. J Am Coll Cardiol Litwin 52 616 2008 10.1016/j.jacc.2008.05.017 Which measures of obesity best predict cardiovascular risk? 

  4. N Engl J Med Pischon 359 2105 2008 10.1056/NEJMoa0801891 General and abdominal adiposity and risk of death in Europe 

  5. JAMA Flegal 288 1723 2002 10.1001/jama.288.14.1723 Prevalence and trends in obesity among US adults, 1999-2000 

  6. J Am Coll Cardiol Lavie 42 677 2003 10.1016/S0735-1097(03)00784-8 Obesity and cardiovascular disease: the Hippocrates paradox? 

  7. JAMA Manson 289 229 2003 10.1001/jama.289.2.229 Obesity in the United States: a fresh look at its high toll 

  8. Public Health Sturm 115 229 2001 10.1016/S0033-3506(01)00449-8 Does obesity contribute as much to morbidity as poverty or smoking? 

  9. J Am Coll Cardiol Ford 50 2128 2007 10.1016/j.jacc.2007.05.056 Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates 

  10. J Am Coll Cardiol Martin 52 1201 2008 10.1016/j.jacc.2008.05.060 Leptin resistance 

  11. Nat Clin Pract Cardiovasc Med Lavie 5 428 2008 10.1038/ncpcardio1257 Untangling the heavy cardiovascular burden of obesity 

  12. Obesity Enriori 14 Suppl 5 254S 2006 10.1038/oby.2006.319 Leptin resistance and obesity 

  13. Nat Clin Pract Cardiovasc Med Romero-Corral 5 418 2008 10.1038/ncpcardio1218 Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population 

  14. Am J Med Sci Alpert 321 225 2001 10.1097/00000441-200104000-00003 Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome 

  15. Circulation Messerli 66 55 1982 10.1161/01.CIR.66.1.55 Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output 

  16. Arch Intern Med Messerli 147 1725 1987 10.1001/archinte.1987.00370100039008 Overweight and sudden death: increased ventricular ectopy in cardiomyopathy of obesity 

  17. N Engl J Med Messerli 314 378 1986 10.1056/NEJM198602063140608 Cardiomyopathy of obesity: a not-so-Victorian disease 

  18. Am J Cardiol Lavie 100 1460 2007 10.1016/j.amjcard.2007.06.040 Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction 

  19. Chest Lavie 92 1042 1987 10.1378/chest.92.6.1042 Left atrial abnormalities indicating diastolic ventricular dysfunction in cardiopathy of obesity 

  20. JAMA Wang 292 2471 2004 10.1001/jama.292.20.2471 Obesity and the risk of new-onset atrial fibrillation 

  21. Am J Cardiol Chakko 68 95 1991 10.1016/0002-9149(91)90718-Z Abnormal left ventricular diastolic filling in eccentric left ventricular hypertrophy of obesity 

  22. Am J Cardiol Garavaglia 62 594 1988 10.1016/0002-9149(88)90662-5 Myocardial contractility and left ventricular function in obese patients with essential hypertension 

  23. Am J Cardiol Alpert 80 736 1997 10.1016/S0002-9149(97)00505-5 Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss 

  24. Am J Med Uretsky 120 863 2007 10.1016/j.amjmed.2007.05.011 Obesity paradox in patients with hypertension and coronary artery disease 

  25. Arch Intern Med Wassertheil-Smoller 160 494 2000 10.1001/archinte.160.4.494 Relation of low body mass to death and stroke in the systolic hypertension in the elderly program 

  26. Hypertension Stamler 17 553 1991 10.1161/01.HYP.17.4.553 Why do lean hypertensive patients have higher mortality rates than other hypertensive patients? 

  27. Am J Med Tuomilehto 90 34S 1991 10.1016/0002-9343(91)90434-Y Body mass index and prognosis in elderly hypertensive patients: a report from the European Working Party on High Blood Pressure in the Elderly 

  28. Am J Med Lavie 120 825 2007 10.1016/j.amjmed.2007.06.023 Obesity, heart disease, and favorable prognosis-truth or paradox? 

  29. N Engl J Med Kenchaiah 347 305 2002 10.1056/NEJMoa020245 Obesity and the risk of heart failure 

  30. J Am Coll Cardiol Horwich 38 789 2001 10.1016/S0735-1097(01)01448-6 The relationship between obesity and mortality in patients with heart failure 

  31. Am J Cardiol Lavie 91 891 2003 10.1016/S0002-9149(03)00031-6 Body composition and prognosis in chronic systolic heart failure: the obesity paradox 

  32. Circulation Lavie 116 II360 2007 Does body composition impact survival in patients with advanced heart failure (abstr) 

  33. Am Heart J Oreopoulos 156 13 2008 10.1016/j.ahj.2008.02.014 Body mass index and mortality in heart failure: a meta-analysis 

  34. Am Heart J Fonarow 153 74 2007 10.1016/j.ahj.2006.09.007 An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the acute decompensated heart failure national registry 

  35. Eur Heart J Lavie 26 5 2005 10.1093/eurheartj/ehi055 Obesity and heart failure prognosis: paradox or reverse epidemiology 

  36. J Am Coll Cardiol Kalantar-Zadeh 43 1439 2004 10.1016/j.jacc.2003.11.039 Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure 

  37. Lancet Anker 361 1077 2003 10.1016/S0140-6736(03)12892-9 Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting enzyme inhibitors: an observational study 

  38. Am J Physiol Mohamed-Ali 277 E971 1999 Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo 

  39. J Am Coll Cardiol Mehra 43 1590 2004 10.1016/j.jacc.2003.10.066 Obesity and suppressed B-type natriuretic peptide levels in heart failure 

  40. Lancet Rauchhaus 356 930 2000 10.1016/S0140-6736(00)02690-8 The endotoxin-lipoprotein hypothesis 

  41. Circulation Hubert 67 968 1983 10.1161/01.CIR.67.5.968 Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study 

  42. J Cardiopulm Rehabil Lavie 25 59 2005 10.1097/00008483-200503000-00001 Cardiac rehabilitation and exercise training programs in metabolic syndrome and diabetes 

  43. J Am Coll Cardiol Gelber 52 605 2008 10.1016/j.jacc.2008.03.066 Measures of obesity and cardiovascular risk among men and women 

  44. Circulation Zhang 117 1658 2008 10.1161/CIRCULATIONAHA.107.739714 Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women 

  45. J Am Coll Cardiol Madala 52 979 2008 10.1016/j.jacc.2008.04.067 Obesity and age of first non-ST-segment elevation myocardial infarction 

  46. Lancet Romero-Corral 368 666 2006 10.1016/S0140-6736(06)69251-9 Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies 

  47. Am J Med Lavie 2009 10.1016/j.amjmed.2009.06.006 The obesity paradox, weight loss, and coronary disease 

  48. Am J Med McAuley 120 518 2007 10.1016/j.amjmed.2006.07.032 Body mass, fitness and survival in veteran patients: another obesity paradox? 

  49. Chest Galal 134 925 2009 10.1378/chest.08-0418 The obesity paradox in patients with peripheral arterial disease: the influence of chronic obstructive pulmonary disease 

  50. Chest Lavie 134 896 2009 10.1378/chest.08-1673 The “obesity paradox”-is smoking/lung disease the explanation? 

  51. Am Heart J Wanahita 155 310 2008 10.1016/j.ahj.2007.10.004 Atrial fibrillation and obesity-results of a meta-analysis 

  52. Arch Intern Med Kurth 162 2557 2002 10.1001/archinte.162.22.2557 Body mass index and the risk of stroke in men 

  53. Chadwick 154 1950 Medical Works of Hippocrates 

  54. Am Heart J Kannel 115 869 1988 10.1016/0002-8703(88)90891-5 Cardiac failure and sudden death in the Framingham Study 

  55. Am J Cardiol el-Gamal 75 956 1995 10.1016/S0002-9149(99)80700-0 Effects of obesity on QT, RR, and QTc intervals 

  56. Proc Soc Exp Biol Med Mshui 220 133 1999 10.3181/00379727-220-44355 QT interval and QT dispersion before and after diet therapy in patients with simple obesity 

  57. Acta Med Scand Rasmussen 217 271 1985 10.1111/j.0954-6820.1985.tb02694.x The relationship between QTc changes and nutrition during weight loss after gastroplasty 

  58. Obes Res Lalani 8 20 2000 10.1038/oby.2000.4 Abnormal signal-averaged electrocardiogram (SAECG) in obesity 

  59. N Engl J Med Trollo 334 99 1996 10.1056/NEJM199601113340207 Obstructive sleep apnea 

  60. Circulation Shamsuzzaman 28 2462 2002 10.1161/01.CIR.0000018948.95175.03 Elevated C-reactive protein in patients with obstructive sleep apnea 

  61. Chest Partinen 94 1200 1988 10.1378/chest.94.6.1200 Long-term outcome for obstructive sleep apnea syndrome patients 

  62. Ann Surg Sugerman 234 41 2001 10.1097/00000658-200107000-00007 Risks and benefits of gastric bypass in morbidly obese patients with severe venous stasis disease 

  63. Arch Intern Med Tsai 162 1182 2002 10.1001/archinte.162.10.1182 Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology 

  64. JAMA Goldhaber 277 642 1997 10.1001/jama.1997.03540320044033 A prospective study of risk factors for pulmonary embolism in women 

  65. J Am Coll Cardiol Fonarow 39 1563 2002 10.1016/S0735-1097(02)01807-7 Obesity, weight reduction and survival in heart failure: reply 

  66. Int J Obes Relat Metab Disord Allison 23 603 1999 10.1038/sj.ijo.0800875 Weight loss increases and fat loss decreases all-cause mortality rates: results from two independent cohort studies 

  67. Eur Cardiovasc Prev Rehabil Sierra-Johnson 15 336 2008 10.1097/HJR.0b013e3282f48348 Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index 

  68. Obes Rev Sorensen 4 3 2003 10.1046/j.1467-789X.2003.00090.x Weight loss causes increased mortality: pros 

  69. N Engl J Med Connolly 337 581 1997 10.1056/NEJM199708283370901 Valvular heart disease associated with fenfluramine-phentermine 

  70. N Engl J Med Albenhaim 335 609 1996 10.1056/NEJM199608293350901 Appetite-suppressant drugs and the risk of primary pulmonary hypertension 

  71. Am Heart J Zannad 144 508 2002 10.1067/mhj.2002.124403 Effects of sibutramine on ventricular dimensions and heart valves in obese patients during weight reduction 

  72. N Engl J Med Knowler 346 393 2002 10.1056/NEJMoa012512 Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin 

  73. N Engl J Med Tuomilehto 344 1343 2001 10.1056/NEJM200105033441801 Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance 

  74. Am J Cardiol Milani 92 50 2003 10.1016/S0002-9149(03)00464-8 Prevalence and profile of metabolic syndrome in patients following acute coronary events and effects of therapeutic lifestyle change with cardiac rehabilitation 

  75. Am J Cardiol Lavie 79 397 1997 10.1016/S0002-9149(97)89239-9 Effects of cardiac rehabilitation, exercise training, and weight reduction on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in obese coronary patients 

  76. J Cardiometab Syndr Lavie 3 136 2008 10.1111/j.1559-4572.2008.00002.x Impact of cardiac rehabilitation on coronary risk factors, inflammation, and the metabolic syndrome in obese coronary patients 

  77. Am J Epidemiol Eilat-Adar 161 352 2005 10.1093/aje/kwi045 Association of intentional changes in body weight with coronary heart disease event rates in overweight subjects who have an additional coronary risk factor 

  78. Am J Cardiol MacMahon 63 202 1989 10.1016/0002-9149(89)90286-5 Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the multiple risk factor intervention trial 

  79. J Am Coll Surg Flum 199 543 2004 10.1016/j.jamcollsurg.2004.06.014 Impact of gastric bypass operation on survival: a population-based analysis 

  80. N Engl J Med Adams 357 753 2007 10.1056/NEJMoa066603 Long-term mortality after gastric bypass surgery 

  81. N Engl J Med Sjostrom 357 741 2007 10.1056/NEJMoa066254 Effects of bariatric surgery on mortality in Swedish obese subjects 

  82. Ann Surg Christou 240 416 2004 10.1097/01.sla.0000137343.63376.19 Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients 

  83. Mayo Clin Proc Batsis 83 897 2008 10.1016/S0025-6196(11)60766-0 Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study 

  84. Am J Cardiol Batsis 102 930 2008 10.1016/j.amjcard.2008.05.040 Cardiovascular risk after bariatric surgery for obesity 

  85. Hypertension Sjostrom 36 20 2000 10.1161/01.HYP.36.1.20 Differentiated long-term effects of intentional weight loss on diabetes and hypertension 

  86. Clin Cardiol Ramani 31 516 2008 10.1002/clc.20315 Safety and efficacy of bariatric surgery in morbidly obese patients with severe systolic heart failure 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로